5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Palliation for all people: Alleviating racial disparities in supportive care for brain metastases
    Editorial

    Wilcox, J. A.; Boire, A. A.
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation
    Journal Article

    Shah, G. L.; DeWolf, S.; Lee, Y. J.; Tamari, R.; Dahi, P. B.; Lavery, J. A.; Ruiz, J.; Devlin, S. M.; Cho, C.; Peled, J. U.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • FXR mediates T cell-intrinsic responses to reduced feeding during infection
    Journal Article

    Campbell, C.; Marchildon, F.; Michaels, A. J.; Takemoto, N.; van der Veeken, J.; Schizas, M.; Pritykin, Y.; Leslie, C. S.; Intlekofer, A. M.; Cohen, P.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2020)

    Fulltext@MSK | Save
  • Shedding of viable SARS-COV-2 after immunosuppressive therapy for cancer
    Research Letter

    Aydillo, T.; Gonzalez-Reiche, A. S.; Aslam, S.; van de Guchte, A.; Khan, Z.; Obla, A.; Dutta, J.; van Bakel, H.; Aberg, J.; García-Sastre, A.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Volumetric analysis of IDH-mutant lower-grade glioma: A natural history study of tumor growth rates before and after treatment
    Journal Article

    Huang, R. Y.; Young, R. J.; Ellingson, B. M.; Veeraraghavan, H.; Wang, W.; Tixier, F.; Um, H.; Nawaz, R.; Luks, T.; Kim, J.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Translation in amino-acid-poor environments is limited by tRNA(Gln) charging
    Journal Article

    Pavlova, N. N.; King, B.; Josselsohn, R. H.; Violante, S.; Macera, V. L.; Vardhana, S. A.; Cross, J. R.; Thompson, C. B.
    eLife (2020)

    Fulltext@MSK | Save
  • Combined JAK2 and ERK1/2 kinase inhibition as a potent therapeutic approach in myeloproliferative neoplasms
    Meeting Abstract

    Brkic, S.; Stivala, S.; Santopolo, A.; Jungius, S.; Passweg, J. R.; Tsakiris, D.; Dirnhofer, S.; Levine, R. L.; Meyer, S. C.
    Swiss Medical Weekly (2020)

    Fulltext@MSK | Save
  • Therapeutic resistance to the novel JAK2 inhibitor CHZ868 in MPN is dependent on MEK-ERK activation and is targetable
    Meeting Abstract

    Szybinski, J.; Codilupi, T.; Wicki, A.; Yang, J. L.; Ghosh, N.; Passweg, J.; Tsakiris, D.; Levine, R. L.; Koche, R.; Meyer, S. C.
    Swiss Medical Weekly (2020)

    Fulltext@MSK | Save
  • Dual genetic targeting of ERK1 and ERK2 reduces the fitness of the malignant clone in myeloproliferative neoplasm mice
    Meeting Abstract

    Stivala, S.; Brkic, S.; Santopolo, A.; Dirnhofer, S.; Passweg, J. R.; Tsakiris, D.; Neel, B.; Levine, R. L.; Meyer, S. C.
    Swiss Medical Weekly (2020)

    Fulltext@MSK | Save
  • Medulloblastoma utilize GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination
    Meeting Abstract

    Martirosian, V.; Deshpande, K.; Zhou, H.; Shen, K.; Stepanosyan, V.; Remsik, J.; Boire, A.; Isakov, D.; De Feyter, H.; Hurth, K.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save